Fzata Raising Series A For New Oral Biologics Platform Modal

/PRNewswire/ -- Fzata, Inc., announces that it is raising series A funding for its first-in-class Bioengineered Probiotic Yeast Medicines (BioPYM™) platform....

Related Keywords

New York , United States , Boston , Massachusetts , United Kingdom , London , City Of , Elizabeth Smith , Zhiyong Yang , Linkedin , Fzata Inc , Prnewswire Fzata Inc , World Congress , Chief Business Officer , Marriott Marquis Times Square , Winter Garden , Fzata , Nc ,